Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CTAS vs GSK✓SelectedUSD · GSKCTAS vs GSK performance historyLatest closeAs of-0.09%11/18
Stock and ETF performance explorer

CTAS vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+110.2%
GSK return
+42.7%
Excess return
+67.5%
Maximum drawdown
-27.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.1%-1.3%+1.3%+0.2%
7D-2.1%-3.1%+1.0%-1.4%
30D+4.8%-0.9%+5.7%+5.0%
3M+11.6%-4.2%+15.7%+12.4%
6M+27.8%-1.6%+29.4%+28.1%
YTD+19.2%+2.6%+16.6%+18.2%
1Y+21.9%+6.2%+15.7%+20.1%
3Y+66.3%+55.0%+11.4%+48.4%
5Y+110.2%+42.8%+67.3%+70.1%
All+110.2%+42.7%+67.5%+70.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling